Kedrion’s global portfolio expands to China to supply human Albumin

Kedrion joined forces with BPL in 2022 This is the first ever approval for a BPL product in China The China Albumin market is the world’s largest Launch commenced in April 2023 FORT LEE, N.J., July 12, 2023 /PRNewswire/ — Kedrion Biopharma, an international biopharmaceutical company…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.